Literature DB >> 22321601

Machine learning amplifies the effect of parental family history of Alzheimer's disease on list learning strategy.

Timothy S Chang1, Michael H Coen, Asenath La Rue, Erin Jonaitis, Rebecca L Koscik, Bruce Hermann, Mark A Sager.   

Abstract

Identification of preclinical Alzheimer's disease (AD) is an essential first step in developing interventions to prevent or delay disease onset. In this study, we examine the hypothesis that deeper analyses of traditional cognitive tests may be useful in identifying subtle but potentially important learning and memory differences in asymptomatic populations that differ in risk for developing Alzheimer's disease. Subjects included 879 asymptomatic higher-risk persons (middle-aged children of parents with AD) and 355 asymptotic lower-risk persons (middle-aged children of parents without AD). All were administered the Rey Auditory Verbal Learning Test at baseline. Using machine learning approaches, we constructed a new measure that exploited finer differences in memory strategy than previous work focused on serial position and subjective organization. The new measure, based on stochastic gradient descent, provides a greater degree of statistical separation (p = 1.44 × 10-5) than previously observed for asymptomatic family history and non-family history groups, while controlling for apolipoprotein epsilon 4, age, gender, and education level. The results of our machine learning approach support analyzing memory strategy in detail to probe potential disease onset. Such distinct differences may be exploited in asymptomatic middle-aged persons as a potential risk factor for AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22321601      PMCID: PMC3348337          DOI: 10.1017/S1355617711001834

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  43 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Early intervention in Alzheimer disease: The importance of APOE4 plus family history.

Authors:  Elizabeth H Corder; John Caskey
Journal:  Neurology       Date:  2009-12-09       Impact factor: 9.910

3.  Explicit memory training leads to improved memory for face-name pairs in patients with mild cognitive impairment: results of a pilot investigation.

Authors:  Benjamin M Hampstead; K Sathian; Anna Bacon Moore; Carrie Nalisnick; Anthony Y Stringer
Journal:  J Int Neuropsychol Soc       Date:  2008-09       Impact factor: 2.892

4.  Visual memory predicts Alzheimer's disease more than a decade before diagnosis.

Authors:  C H Kawas; M M Corrada; R Brookmeyer; A Morrison; S M Resnick; A B Zonderman; D Arenberg
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

5.  Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study.

Authors:  P M Greenwood; Chantal Lambert; Trey Sunderland; Raja Parasuraman
Journal:  Neuropsychology       Date:  2005-03       Impact factor: 3.295

6.  Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  J Neuropathol Exp Neurol       Date:  1990-05       Impact factor: 3.685

7.  The predictive value of memory strategies for Alzheimer's disease in subjects with mild cognitive impairment.

Authors:  Inez H G B Ramakers; Pieter Jelle Visser; Pauline Aalten; Helene L Maes; Hendrika G M Lansdaal; Celeste J C Meijs; Jelle Jolles; Frans R J Verhey
Journal:  Arch Clin Neuropsychol       Date:  2009-12-01       Impact factor: 2.813

8.  Distinct serial position profiles and neuropsychological measures differentiate late life depression from normal aging and Alzheimer's disease.

Authors:  Nancy S Foldi; Adam M Brickman; Lynn A Schaefer; Margaret E Knutelska
Journal:  Psychiatry Res       Date:  2003-08-30       Impact factor: 3.222

9.  Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.

Authors:  P van Vliet; R G J Westendorp; P Eikelenboom; H C Comijs; M Frölich; E Bakker; W van der Flier; E van Exel
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

10.  Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?

Authors:  N T Lautenschlager; L A Cupples; V S Rao; S A Auerbach; R Becker; J Burke; H Chui; R Duara; E J Foley; S L Glatt; R C Green; R Jones; H Karlinsky; W A Kukull; A Kurz; E B Larson; K Martelli; A D Sadovnick; L Volicer; S C Waring; J H Growdon; L A Farrer
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  4 in total

Review 1.  Advancing Alzheimer's research: A review of big data promises.

Authors:  Rui Zhang; Gyorgy Simon; Fang Yu
Journal:  Int J Med Inform       Date:  2017-07-24       Impact factor: 4.046

2.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

3.  Cognitive activities and cognitive performance in middle-aged adults at risk for Alzheimer's disease.

Authors:  Erin Jonaitis; Asenath La Rue; Kimberly D Mueller; Rebecca L Koscik; Bruce Hermann; Mark A Sager
Journal:  Psychol Aging       Date:  2013-12

4.  Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors.

Authors:  Joshua S Talboom; Asta Håberg; Matthew D De Both; Marcus A Naymik; Isabelle Schrauwen; Candace R Lewis; Stacy F Bertinelli; Callie Hammersland; Mason A Fritz; Amanda J Myers; Meredith Hay; Carol A Barnes; Elizabeth Glisky; Lee Ryan; Matthew J Huentelman
Journal:  Elife       Date:  2019-06-18       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.